Primary cutaneous CD30+ T-cell lymphoproliferative disorders: Retrospective study of 22 patients

被引：0

作者：

Carvalho, R. ^{[1
]}

Gasparinho, G. ^{[2
]}

Sachse, M. F. ^{[3
]}

Cabecadas, J. ^{[2
]}

Cravo, M. ^{[3
]}

Rafael, M. ^{[3
]}

Moura, C. ^{[3
]}

Alvarez, R. ^{[4
]}

Almeida, A. ^{[4
]}

Pecegueiro, M. ^{[3
]}

机构：

[1] Curry Cabral Hosp, Dept Dermatol, Lisbon, Portugal

[2] Inst Portugues Oncol Francisco Gentil, Dept Pathol, Lisbon, Portugal

[3] Inst Portugues Oncol Francisco Gentil, Dept Dermatol, Lisbon, Portugal

[4] Inst Portugues Oncol Francisco Gentil, Dept Hematol, Lisbon, Portugal

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2011年 / 9卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：13 / 14

页数：2

共 50 条

[1] CD30+ T-cell lymphoproliferative disorders
Martin, James M.
Wu, Hong
Barta, Stefan K.
CHINESE CLINICAL ONCOLOGY, 2019, 8 (01)
[2] Primary cutaneous CD30+ lymphoproliferative disorders
Wieser, Iris
Tetzlaff, Michael T.
Cabala, Carlos A. Torres
Duvic, Madeleine
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (08): : 767 - 782
[3] A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders
Chen, Cynthia
Gu, Yuhan D.
Geskin, Larisa J.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (01) : 121 - +
[4] Primary cutaneous CD8+ and CD30+ T-cell lymphoproliferative disorders: case reports and clinical implications
Pamela Baldin
Myat Marla Shwe
Liliane Marot
Pascal Van Van Eeckout
Claire Dachelet
Laurine Sacré
Aline Berners
Stephanie Olivier
Alessandra Camboni
European Journal of Dermatology, 2019, 29 : 39 - 44
[5] Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30+ lymphoproliferative disorders
Greisser, Johannes
Palmedo, Gabriele
Sander, Christian
Kutzner, Heinz
Kazakov, Dmitry V.
Roos, Malgorzata
Burg, Guenter
Kempf, Werner
JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (11) : 711 - 715
[6] Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review
Cosimo Di Raimondo
Vishwas Parekh
Joo Y. Song
Steven T. Rosen
Christiane Querfeld
Jasmine Zain
Xochiquetzal U. Martinez
Farah R. Abdulla
Current Hematologic Malignancy Reports, 2020, 15 : 333 - 342
[7] Primary cutaneous CD30+ lymphoproliferative disorders have a CD4+ cytotoxic T cell phenotype
Vermeer, MH
Kummer, JA
Meijer, CJLM
Willemze, MR
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 490 - 490
[8] Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 10 - 11
[9] Signet Ring Cell Primary Cutaneous CD30+ Lymphoproliferative Disorder Presenting as a Monomorphic T-Cell Posttransplant Lymphoproliferative Disease
Papalas, John A.
Kulbacki, Evan L.
Park, H. Kim
Howell, Eric R.
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (07) : E94 - E96
[10] How I treat primary cutaneous CD30+ lymphoproliferative disorders
Shinohara, Michi M.
Shustov, Andrei
BLOOD, 2019, 134 (06) : 515 - 524

← 1 2 3 4 5 →